With the ends in sight: images from the BRCA1 tumor suppressor

@article{Baer2001WithTE,
  title={With the ends in sight: images from the BRCA1 tumor suppressor},
  author={Richard J. Baer},
  journal={Nature Structural Biology},
  year={2001},
  volume={8},
  pages={822-824}
}
  • R. Baer
  • Published 1 October 2001
  • Biology, Medicine
  • Nature Structural Biology
Structures of two regions of BRCA1 offer important insights into the molecular properties of this tumor suppressor. 

Figures and Topics from this paper

Cancer risk assessment at the atomic level.
A flurry of articles on the structure of different domains of BRCA1 and BRCA2 have not only shed light on the biology of these proteins but have also raised hopes that these data could eventually be
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
TLDR
What is known about the biological functions of the BRCA proteins is examined and how their disruption can induce susceptibility to specific types of cancer is asked.
Highlight: BRCA1 and BRCA2 proteins in breast cancer
  • D. C. Daniel
  • Biology, Medicine
    Microscopy research and technique
  • 2002
Heterozygous carriers of loss‐of‐function germline mutations in the BRCA1 or BRCA2 breast cancer susceptibility genes have a predisposition to breast and ovarian cancer. Multiple functions have been
BCR-ABL Hits at Mitosis; Implications for Chromosomal Instability, Aneuploidy and Therapeutic Strategy
TLDR
It was shown that the aberrations associated with the progression of BCR-ABLpositive CML chronic phase to the aggressive blast crisis include additional chromosomes (Ph1, +8, +19), isochromosome 17q (associated with the loss of p53), and complex chromosomal rearrangements (CCR).
Nuclear–cytoplasmic translocation of BARD1 is linked to its apoptotic activity
TLDR
It is suggested that nuclear and cytoplasmic localization of BARD1 reflect its dual function and that the increased cytopLasmic localized of Bard1 is associated with apoptosis.
Understanding Germ-Line Mutations in BRCA1
TLDR
The fact that a significant proportion of BRCA1 variants remain unclassified represents a gap in risk assessment, such that individuals undergoing genetic testing will receive non-informative test results.
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
TLDR
In advanced-stage HGSOC, patients with germline BRCA1/2 mutations have better prognosis with longer PFS than those lacking BRCa mutations.
Predicting ovarian/breast cancer pathogenic risks of BRCA1 gene variants of unknown significance
TLDR
The optimized random forest model predicted 4724 benign and 1591 pathogenic variants, which helped the interpretation of these variants of unknown significance and diagnosis, and developed machine learning models so as to predict the pathogenicity for variants with unknown clinical significance.
Meeting Report: Structural Determination of Environmentally Responsive Proteins
  • L. Reinlib
  • Biology, Medicine
    Environmental health perspectives
  • 2005
TLDR
A workshop of experts in structural determination and environmental health to solicit advice for future research in structural resolution relative to environmentally responsive proteins and pathways found value in improving the throughput and purity of protein samples and macromolecular assemblies.
Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
TLDR
This work identified BRCA1 gene variants with unknown clinical significance from clinical sequencing data, and developed machine learning models so as to predict the pathogenicity for variants withunknown clinical significance, which outperformed other models.
...
1
2
...

References

SHOWING 1-10 OF 22 REFERENCES
In search of the tumour-suppressor functions of BRCA1 and BRCA2
TLDR
What is known of BRCA gene function is analyzed and some unanswered questions in the field are highlighted to highlight the need to understand more fully the functions and responsibilities of this gene.
The BRCA1 C-terminal domain: structure and function.
TLDR
The sequence and functional diversity of the BRCT superfamily suggests that BRCT domains are evolutionarily convenient interaction modules.
Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1
TLDR
The structure provides a basis to predict the structural consequences of uncharacterized BRCA1 mutations and may represent a general mode of interaction between homologous domains within proteins that interact to regulate the cellular response to DNA damage.
Structure of a BRCA1–BARD1 heterodimeric RING–RING complex
TLDR
The BRCA1–BARD1 structure provides a model for its ubiquitin ligase activity, illustrates how the BRCa1 RING domain can be involved in associations with multiple protein partners and provides a framework for understanding cancer-causing mutations at the molecular level.
Roles of BRCA1 and its interacting proteins
  • Chu‐Xia Deng, S. Brodie
  • Biology, Medicine
    BioEssays : news and reviews in molecular, cellular and developmental biology
  • 2000
TLDR
This review examines the understanding of the significance of the interactions between BRCA1 and other proteins, through which BRCa1 maintains genome integrity and represses tumor formation.
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
TLDR
This BRCA1–associated RING domain (BARD1) protein contains an N–terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCa1.
Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
TLDR
It is reported that BRCA1 exhibits a bona fide ubiquitin (Ub) protein ligase (E3) activity, and that cancer-predisposing mutations within the B RCA1 RING domain abolish its Ub ligase activity.
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.
  • Y. Jin, X. L. Xu, +4 authors R. Baer
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 1997
TLDR
It is shown that the steady-state levels of BARD1, unlike those of BRCA1, remain relatively constant during cell cycle progression, and this cell cycle-dependent colocalization of Bard1 and BRC a1 indicates a role for BARD 1 in BRCa1-mediated tumor suppression.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods. Probable predisposing mutations have
Structure of an XRCC1 BRCT domain: a new protein–protein interaction module
TLDR
The first three‐dimensional structure and fold of a BRCT domain determined by X‐ray crystallography at 3.2 Å resolution is described and the established structure of an XRCC1 BRCT homodimer suggests potential protein–protein interaction sites for the complementaryBRCT domain in DNA ligase III.
...
1
2
3
...